Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: JAMA Pediatr. 2015 Apr 1;169(4):341–348. doi: 10.1001/jamapediatrics.2014.3804

Table 1.

Summary of Palivizumab Regimens

Regimen (Source) Total No. of Doses Days of Coverage Date of First Dose Interval, d
Between Doses 1 and 2 After Dose 2
Seasonal (Pickering et al,11 2014) 5 159 Onset of local RSV season 30 30
NOV1 (Pickering et al,11 2014) 5 159 Nov 1 30 30
MED30 (Panozzo et al,17 2010) 5 159 30 d before onset of 5 past local seasons 30 30
OFS (present study) 5 181 Optimized to local RSV dataa 29 38
OFS4 (present study) 4 143
OFS3 (present study) 3 105

Abbreviations: MED30, initiates injections 30 days before the median start date across the 5 most recent RSV seasons; NOV1, recommends the first injection occur on November 1; OFS, optimized fixed start; OFS3, 3-injection OFS; OFS4, 4-injection OFS; RSV, respiratory syncytial virus.

a

Injections are timed so to achieve protective concentrations of palivizumab on days of the year when the hospitalization rate is the highest based on local data from previous seasons.